Urothelial Carcinoma: Muscle-Invasive and Metastatic Disease
Author and Disclosure Information [Show]

Timothy Lindsay, MD
Lewis Katz School of Medicine, Temple University Health System, Philadelphia, PA

Matthew Zibelman, MD

Assistant Professor of Genitourinary Medical Oncology, Fox Chase Cancer Center, Philadelphia PA

Question 1 of 5

A 70-year-old man with a past medical history of tobacco abuse is evaluated by his urologist for hematuria. An initial diagnostic cystoscopy reveals a single 0.8-cm papillary nodule. A biopsy is performed, which reveals high-grade urothelial carcinoma.

What is the next best step in the evaluation of this patient’s cancer stage?

Follow up in 3 months for repeat cystoscopy to evaluate for disease progression

Obtain a computed tomography (CT) scan with and without contrast of the chest, abdomen, and pelvis

Perform an intravenous pyelogram

Schedule the patient for cystectomy with regional lymph node dissection

Schedule the patient for positron emission tomography (PET)-CT imaging

Schedule the patient for transurethral resection of bladder tumor

Hospital Physician: Hematology/Oncology. 2018 August;13(4)

This quiz is not accredited for CME.

More from Board Review Questions: Hematology/Oncology


Management of Advanced Melanoma
Castration-Resistant Prostate Cancer
Transfusion Reactions (part 2)
Transfusion Reactions (part 1)
Plasma Cell Disorders (part 3)
Plasma Cell Disorders (part 2)
Chronic Myeloid Leukemia
Aplastic Anemia
Small Cell Lung Cancer
Management of Metastatic Gastric Cancer
Transfusion Medicine
Management of Colorectal Cancer in Older Adults
Acute Myeloid Leukemia
Aggressive B-Cell Non-Hodgkin Lymphoma
Pancreatic Adenocarcinoma: Advanced Unresectable and Metastatic Disease
HER2-Positive Breast Cancer
Von Willebrand Disease: Assessment and Diagnostic Testing
Von Willebrand Disease: Clinical Management
Pancreatic Adenocarcinoma: Neoadjuvant and Adjuvant Treatment
Late Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Polycythemia Vera and Essential Thrombocythemia: Current Management
Treatment of Biliary Tract Cancers
Early Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Hairy Cell Leukemia
Genomic Testing in Women with Early-Stage Hormone Receptor–Positive, HER2-Negative Breast Cancer
Immune Thrombocytopenia
Cancer-Related Fatigue
Disseminated Intravascular Coagulation
Advanced Stage and Relapsed/Refractory Hodgkin Lymphoma
Adjuvant Chemotherapy for Colon Cancer
Molecular Markers and Targeted Therapies in the Management of Non-Small Cell Lung Cancer
Metastatic Cutaneous Melanoma: Targeted Therapy and Immunotherapy
Thrombosis in Pregnancy
Locally Advanced Pancreatic Cancer
Early-Stage Hodgkin Lymphoma
Neoadjuvant and Adjuvant Therapy for Gastric Cancer
Hemophilia A and B
Mantle Cell Lymphoma
Soft Tissue Sarcoma
Sickle Cell Disease
Renal Cell Carcinoma
Management of Locally Advanced Rectal Adenocarcinoma
Adjuvant Systemic Therapy for Early-Stage Breast Cancer
Chronic Myeloid Leukemia
Plasma Cell Disorders
Myelodysplastic Syndromes
Acute and Chronic Graft-versus-Host Disease